Keeping Up With Advances in Retinal Disease Therapeutics

Keeping Up With Advances in Retinal Disease Therapeutics
Media formats available:
Details
Presenters
  • Overview

    Natalie Huang, MD, discusses incorporating new and emerging therapies for neovascular age-related macular degeneration and diabetic eye disease into your clinic to alleviate the high treatment burden and other barriers to optimal outcomes that patients experience. Dr. Huang shares insights into how home monitoring systems and AI technologies may be used to benefit patients. 

    This content was captured during a synchronous in-person and virtual symposium. Polling took place during the symposium.

     

    This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Identify patients who experience a high treatment burden and/or barriers to optimal outcomes with first-generation anti-VEGF therapies
    • Review recent and emerging advances in therapies for neovascular age-related macular degeneration (nAMD) and diabetic eye disease
    • Design treatment and follow-up regimens that optimize safety, efficacy, and durability outcomes with second-generation and pipeline therapies for nAMD and diabetic eye disease
    • Describe the role that home monitoring and artificial intelligence can play in improving patient adherence and treatment outcomes
  • Accreditation

    Provided by Evolve Medical Education 

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Evolve designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Participation Method

    In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

  • Faculty and Disclosures

    Natalie Huang, MD

    Natalie Huang, MD

    Retinal Consultants Medical Group
    Sacramento, CA

     

    DISCLOSURE POLICY
    It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

    The following faculty/staff members have the following financial relationships with ineligible companies.

    Natalie Huang, MD, has had no financial relationships or affiliations with ineligible companies.

    The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals, Inc.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying Evolve Medical Education…
but how about a more personalized experience?

Register for free